Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 1
1989 8
1990 15
1991 3
1992 18
1993 16
1994 12
1995 19
1996 12
1997 16
1998 7
1999 7
2000 4
2001 9
2002 6
2003 6
2004 3
2005 4
2006 4
2007 4
2009 2
2010 1
2011 2
2012 2
2014 5
2015 4
2016 1
2019 1
2020 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

193 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Efficacy of treatments for anxiety disorders: a meta-analysis.
Bandelow B, Reitt M, Röver C, Michaelis S, Görlich Y, Wedekind D. Bandelow B, et al. Int Clin Psychopharmacol. 2015 Jul;30(4):183-92. doi: 10.1097/YIC.0000000000000078. Int Clin Psychopharmacol. 2015. PMID: 25932596 Review.
In direct comparisons with control groups, all investigated drugs, except for citalopram, opipramol and moclobemide, were significantly more effective than placebo. Individual CBT was more effective than waiting list, psychological placebo and pill placebo. ...
In direct comparisons with control groups, all investigated drugs, except for citalopram, opipramol and moclobemide, were significant …
Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis.
Serretti A, Chiesa A. Serretti A, et al. J Clin Psychopharmacol. 2009 Jun;29(3):259-66. doi: 10.1097/JCP.0b013e3181a5233f. J Clin Psychopharmacol. 2009. PMID: 19440080 Review.
No significant difference with placebo was found for the following antidepressants: agomelatine, amineptine, bupropion, moclobemide, mirtazapine, and nefazodone. DISCUSSION: Treatment-emergent SD caused by antidepressants is a considerable issue with a large variation acro …
No significant difference with placebo was found for the following antidepressants: agomelatine, amineptine, bupropion, moclobemide, …
Comparative efficacy and tolerability of pharmacological treatments for the treatment of acute bipolar depression: A systematic review and network meta-analysis.
Bahji A, Ermacora D, Stephenson C, Hawken ER, Vazquez G. Bahji A, et al. J Affect Disord. 2020 May 15;269:154-184. doi: 10.1016/j.jad.2020.03.030. Epub 2020 Mar 20. J Affect Disord. 2020. PMID: 32339131 Review.
RESULTS: Identified citations (4,404) included 50 trials comprising 11,448 participants. Escitalopram, phenelzine, moclobemide, carbamazepine, sertraline, lithium, paroxetine, aripiprazole, gabapentin and ziprasidone appear to be ineffective as compared to placebo in treat …
RESULTS: Identified citations (4,404) included 50 trials comprising 11,448 participants. Escitalopram, phenelzine, moclobemide, carba …
Bioavailability of moclobemide from two formulation tablets in healthy humans.
Główka FK, Hermann TW, Danielak D, Zabel M, Hermann J. Główka FK, et al. Pharmazie. 2019 Feb 1;74(2):97-100. doi: 10.1691/ph.2019.8819. Pharmazie. 2019. PMID: 30782258 Clinical Trial.
Carbamazepine was proposed as an internal standard and ammonia as well as Na2HPO4 as alkalizing agents for the mobile phase and the liquid-liquid extraction of moclobemide from human blood plasma, respectively. Basic pharmacokinetic parameters of moclobemide obtaine …
Carbamazepine was proposed as an internal standard and ammonia as well as Na2HPO4 as alkalizing agents for the mobile phase and the liquid-l …
Moclobemide versus tranylcypromine in the treatment of depression.
Rossel L, Moll E. Rossel L, et al. Acta Psychiatr Scand Suppl. 1990;360:61-2. doi: 10.1111/j.1600-0447.1990.tb05333.x. Acta Psychiatr Scand Suppl. 1990. PMID: 2248075 Clinical Trial.
Moclobemide and tranylcypromine were compared in 2 randomized groups of 20 depressed patients each. ...The dosage was 150-300 mg moclobemide and 15-30 mg tranylcypromine daily. At the end of treatment, improvement on the Hamilton Rating Scale for Depression was 59.3
Moclobemide and tranylcypromine were compared in 2 randomized groups of 20 depressed patients each. ...The dosage was 150-300 mg m
Moclobemide in social phobia: a controlled dose-response trial.
Noyes R Jr, Moroz G, Davidson JR, Liebowitz MR, Davidson A, Siegel J, Bell J, Cain JW, Curlik SM, Kent TA, Lydiard RB, Mallinger AG, Pollack MH, Rapaport M, Rasmussen SA, Hedges D, Schweizer E, Uhlenhuth EH. Noyes R Jr, et al. J Clin Psychopharmacol. 1997 Aug;17(4):247-54. doi: 10.1097/00004714-199708000-00002. J Clin Psychopharmacol. 1997. PMID: 9241002 Clinical Trial.
Moclobemide was well tolerated, insomnia being the only dose-related adverse event observed with the drug. In this dose-response trial, moclobemide did not demonstrate efficacy at 12 weeks. Some other controlled studies have found moclobemide and brofaromine,
Moclobemide was well tolerated, insomnia being the only dose-related adverse event observed with the drug. In this dose-response tria
Moclobemide and fluoxetine for panic disorder. International Panic Disorder Study Group.
Tiller JW, Bouwer C, Behnke K. Tiller JW, et al. Eur Arch Psychiatry Clin Neurosci. 1999;249 Suppl 1:S7-10. doi: 10.1007/pl00014164. Eur Arch Psychiatry Clin Neurosci. 1999. PMID: 10361960 Clinical Trial.
The efficacy data showed no significant difference between moclobemide and fluoxetine. Both had acute efficacy, with 63% moclobemide and 70% fluoxetine patients (ns) panic free at 8 weeks. Both agents were well tolerated to 8 weeks, but moclobemide had fewer …
The efficacy data showed no significant difference between moclobemide and fluoxetine. Both had acute efficacy, with 63% moclobemi
Moclobemide and placebo in mild major depression: a double-blind randomized trial.
Ose E, Holm P. Ose E, et al. Psychopharmacology (Berl). 1992;106 Suppl:S114-5. doi: 10.1007/BF02246251. Psychopharmacology (Berl). 1992. PMID: 1546122 Clinical Trial.
Sixty-eight patients participated in this double-blind randomized study with moclobemide versus placebo (35 allocated to moclobemide; 33 to placebo). ...Adverse events were observed in 31% of patients in the moclobemide group and in 18% of patients in the pla …
Sixty-eight patients participated in this double-blind randomized study with moclobemide versus placebo (35 allocated to moclobemi
Moclobemide versus fluoxetine in the treatment of major depressive disorder in adults.
Lapierre YD, Joffe R, McKenna K, Bland R, Kennedy S, Ingram P, Reesal R, Rickhi BG, Beauclair L, Chouinard G, Annable L. Lapierre YD, et al. J Psychiatry Neurosci. 1997 Mar;22(2):118-26. J Psychiatry Neurosci. 1997. PMID: 9074306 Free PMC article. Clinical Trial.
There were 128 patients eligible to be randomized, with 66 patients receiving moclobemide and 62 patients receiving fluoxetine. At the termination of the study, patients in the moclobemide group were receiving a mean dose of 440 mg +/- 123 mg, while the mean dose in …
There were 128 patients eligible to be randomized, with 66 patients receiving moclobemide and 62 patients receiving fluoxetine. At th …
Moclobemide versus fluoxetine in the treatment of inpatients with major depression.
Gattaz WF, Vogel P, Kick H, Kohnen R. Gattaz WF, et al. J Clin Psychopharmacol. 1995 Aug;15(4 Suppl 2):35S-40S. doi: 10.1097/00004714-199508001-00007. J Clin Psychopharmacol. 1995. PMID: 7593728 Clinical Trial.
The HAM-D responder rate (50% improvement from baseline) was 59% in the moclobemide group and 58% in the fluoxetine group after 4 weeks. Moclobemide, however, acted therapeutically faster than fluoxetine. ...There were no differences between moclobemide and f …
The HAM-D responder rate (50% improvement from baseline) was 59% in the moclobemide group and 58% in the fluoxetine group after 4 wee …
193 results